Back
Intellia Therapeutics, Inc. Vs. BlueLinx Holdings, Inc. Industry Stock Comparison
Sell
22
NTLA
Intellia Therapeutics, Inc.
Last Price:
$9.59
Seasonality Move:
-6.88%
Buy
56
BXC
BlueLinx Holdings, Inc.
Last Price:
$62.39
Seasonality Move:
23.8%
Sell
22
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Is Intellia Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Intellia Therapeutics, Inc. [NTLA] share price is $9.59. The Score for NTLA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
BlueLinx Holdings, Inc. (BXC)
is a Buy
Is BlueLinx Holdings, Inc. a Buy, Sell or Hold?
-
The current BlueLinx Holdings, Inc. [BXC] share price is $62.46. The Score for BXC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTLA Stock Price Chart
What is Intellia Therapeutics, Inc.'s stock price today?
-
The Intellia Therapeutics, Inc. share price today is $9.59The current trend is relatively stagnant and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BXC Stock Price Chart
What is BlueLinx Holdings, Inc.'s stock price today?
-
The BlueLinx Holdings, Inc. share price today is $62.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BXC is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 47.26 | Sell |
| Chaikin Money Flow: | 1208875 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.45 - 9.51) | Buy |
| Bollinger Bands (100): | (7.99 - 18.91) | Sell |
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 50.05 | Buy |
| Chaikin Money Flow: | 22434 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.59 - 64.53) | Buy |
| Bollinger Bands (100): | (61.75 - 78.81) | Sell |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.23 | Buy |
| 20-day SMA: | 9.15 | Buy |
| 50-day SMA: | 12.44 | Sell |
| 200-day SMA: | 11.33 | Sell |
| 8-day EMA: | 9.34 | Buy |
| 20-day EMA: | 9.48 | Buy |
| 50-day EMA: | 11.2 | Sell |
| 200-day EMA: | 12.77 | Sell |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.36 | Sell |
| 20-day SMA: | 62.54 | Sell |
| 50-day SMA: | 63.45 | Sell |
| 200-day SMA: | 71.99 | Sell |
| 8-day EMA: | 62.78 | Sell |
| 20-day EMA: | 62.4 | Buy |
| 50-day EMA: | 64.18 | Sell |
| 200-day EMA: | 74.48 | Sell |
Intellia Therapeutics, Inc. Earnings Growth & NTLA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.
BlueLinx Holdings, Inc. Earnings Growth & BXC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.29 per share, and an increase next year of $0.86 per share.
Intellia Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BlueLinx Holdings, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||